JMDC Inc is engaged in constructing and providing a medical database, offering PHR and other health promotion services, telemedicine such as diagnostic imaging, and providing digital solutions to dispensing pharmacies.
2002
178
LTM Revenue $291M
LTM EBITDA $79.4M
$1.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
JMDC has a last 12-month revenue of $291M and a last 12-month EBITDA of $79.4M.
In the most recent fiscal year, JMDC achieved revenue of $215M and an EBITDA of $61.5M.
JMDC expects next 12-month revenue of XXX and NTM EBITDA of XXX
See JMDC valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $185M | $215M | XXX | XXX | XXX |
Gross Profit | $83.7M | $105M | XXX | XXX | XXX |
Gross Margin | 45% | 49% | XXX | XXX | XXX |
EBITDA | $53.0M | $61.5M | XXX | XXX | XXX |
EBITDA Margin | 29% | 29% | XXX | XXX | XXX |
Net Profit | $21.7M | $28.4M | XXX | XXX | XXX |
Net Margin | 12% | 13% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 25, 2025, JMDC's stock price is JPY 3164 (or $21).
JMDC has current market cap of JPY 207B (or $1.4B), and EV of JPY 225B (or $1.5B).
See JMDC trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.5B | $1.4B | XXX | XXX | XXX | XXX | $0.66 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 25, 2025, JMDC has market cap of $1.4B and EV of $1.5B.
JMDC's trades at 5.1x LTM EV/Revenue multiple, and 18.8x LTM EBITDA.
Analysts estimate JMDC's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for JMDC and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $1.5B | XXX | XXX | XXX |
EV/Revenue | 5.5x | XXX | XXX | XXX |
EV/EBITDA | 20.2x | XXX | XXX | XXX |
P/E | 34.7x | XXX | XXX | XXX |
P/E/Growth | 1.4x | XXX | XXX | XXX |
EV/FCF | -179.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpJMDC's NTM/LTM revenue growth is 19%
JMDC's revenue per employee for the last fiscal year averaged $1.2M, while opex per employee averaged $0.5M for the same period.
Over next 12 months, JMDC's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate JMDC's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for JMDC and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 16% | XXX | XXX | XXX | XXX |
EBITDA Margin | 27% | XXX | XXX | XXX | XXX |
EBITDA Growth | 16% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 46% | XXX | XXX | XXX | XXX |
Revenue per Employee | $1.2M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.5M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 37% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 38% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Beamtree | XXX | XXX | XXX | XXX | XXX | XXX |
Cogstate | XXX | XXX | XXX | XXX | XXX | XXX |
Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
Impedimed | XXX | XXX | XXX | XXX | XXX | XXX |
Proteomics International | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
JMDC acquired XXX companies to date.
Last acquisition by JMDC was XXXXXXXX, XXXXX XXXXX XXXXXX . JMDC acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was JMDC founded? | JMDC was founded in 2002. |
Where is JMDC headquartered? | JMDC is headquartered in Japan. |
How many employees does JMDC have? | As of today, JMDC has 178 employees. |
Who is the CEO of JMDC? | JMDC's CEO is Mr. Ryo Noguchi. |
Is JMDC publicy listed? | Yes, JMDC is a public company listed on TKS. |
What is the stock symbol of JMDC? | JMDC trades under 4483 ticker. |
When did JMDC go public? | JMDC went public in 2019. |
Who are competitors of JMDC? | Similar companies to JMDC include e.g. Beamtree, Cogstate, Echo IQ, Impedimed. |
What is the current market cap of JMDC? | JMDC's current market cap is $1.4B |
What is the current revenue of JMDC? | JMDC's last 12-month revenue is $291M. |
What is the current EBITDA of JMDC? | JMDC's last 12-month EBITDA is $79.4M. |
What is the current EV/Revenue multiple of JMDC? | Current revenue multiple of JMDC is 5.1x. |
What is the current EV/EBITDA multiple of JMDC? | Current EBITDA multiple of JMDC is 18.8x. |
What is the current revenue growth of JMDC? | JMDC revenue growth between 2023 and 2024 was 16%. |
Is JMDC profitable? | Yes, JMDC is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.